{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:29:13Z","timestamp":1791779353087,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["H2020-ITN 766181"],"award-info":[{"award-number":["H2020-ITN 766181"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["33-729.55-3\/214"],"award-info":[{"award-number":["33-729.55-3\/214"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 2388\/33-1"],"award-info":[{"award-number":["INST 2388\/33-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transplantation of stem cell-derived \u03b2-cells is a promising therapeutic advancement in the treatment of type 1 diabetes mellitus. A current limitation of this approach is the long differentiation timeline that generates a heterogeneous population of pancreatic endocrine cells. To address this limitation, an inducible lentiviral overexpression system of mature \u03b2-cell markers was introduced into human induced-pluripotent stem cells (hiPSCs). Following the selection of the successfully transduced hiPSCs, the cells were treated with doxycycline in the pancreatic progenitor induction medium to support their transition toward the pancreatic lineage. Cells cultured with doxycycline presented the markers of interest, NGN3, PDX1, and MAFA, after five days of culture, and glucose-stimulated insulin secretion assays demonstrated that the cells were glucose-responsive in a monolayer culture. When cultured as a spheroid, the markers of interest and insulin secretion in a static glucose-stimulated insulin secretion assay were maintained; however, insulin secretion upon consecutive glucose challenges was limited. Comparison to human fetal and adult donor tissues identified that although the hiPSC-derived spheroids present similar markers to adult insulin-producing cells, they are functionally representative of fetal development. Together, these results suggest that with optimization of the temporal expression of these markers, forward programming of hiPSCs towards insulin-producing cells could be a possible alternative for islet transplantation.<\/jats:p>","DOI":"10.1038\/s41598-024-64346-4","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:01:57Z","timestamp":1718244117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA"],"prefix":"10.1038","volume":"14","author":[{"given":"Abiramy","family":"Jeyagaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Urbanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Layland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Schenke-Layland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"64346_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-3271-3","volume-title":"The Islets Of Langerhans","author":"S Islam","year":"2010","unstructured":"Islam, S. The Islets Of Langerhans (Advances in Experimental Medicine and Biology, Springer, Cham, 2010)."},{"key":"64346_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/jcm7030054","volume":"7","author":"G Xavier","year":"2018","unstructured":"Xavier, G. The cells of the islets of langerhans. J. Clin. Med. 7, 54 (2018).","journal-title":"J. Clin. Med."},{"key":"64346_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/ds18-0091","volume":"32","author":"C Berget","year":"2019","unstructured":"Berget, C., Messer, L. H. & Forlenza, G. P. A clinical overview of insulin pump therapy for the management of diabetes: Past, present, and future of intensive therapy. Diabetes Spectr. 32, 194\u2013204 (2019).","journal-title":"Diabetes Spectr."},{"key":"64346_CR4","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jc.2013-1589","volume":"98","author":"RS Weinstock","year":"2013","unstructured":"Weinstock, R. S. et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: Results from the T1D Exchange clinic registry. J. Clin. Endocrinol. Metab. 98, 3411\u20133419 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"64346_CR5","unstructured":"Robertson, R. P. Pancreas and islet transplantation in diabetes mellitus. Wolters Kluwer (2019)."},{"key":"64346_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114481","volume":"189","author":"A Jeyagaran","year":"2022","unstructured":"Jeyagaran, A. et al. Type 1 diabetes and engineering enhanced islet transplantation. Adv. Drug Deliv. Rev. 189, 114481 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"64346_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/MOT.0b013e3283337e1c","volume":"15","author":"CN Mayhew","year":"2010","unstructured":"Mayhew, C. N. & Wells, J. M. Converting human pluripotent stem cells into beta-cells: Recent advances and future challenges. Curr. Opin. Organ Transplant. 15, 54\u201360 (2010).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"64346_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100238","volume":"2","author":"KG Maxwell","year":"2021","unstructured":"Maxwell, K. G. & Millman, J. R. Applications of iPSC-derived beta cells from patients with diabetes. Cell reports. Med. 2, 100238 (2021).","journal-title":"Cell reports. Med."},{"key":"64346_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121\u20131133 (2014).","journal-title":"Nat. Biotechnol."},{"key":"64346_CR10","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1038\/s41467-021-23525-x","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. Chemical combinations potentiate human pluripotent stem cell-derived 3D pancreatic progenitor clusters toward functional beta cells. Nat. Commun. 12, 3330 (2021).","journal-title":"Nat. Commun."},{"key":"64346_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1900\/RDS.2014.11.19","volume":"11","author":"J Chmielowiec","year":"2014","unstructured":"Chmielowiec, J. & Borowiak, M. In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors. Rev. Diabet. Stud. 11, 19\u201334 (2014).","journal-title":"Rev. Diabet. Stud."},{"key":"64346_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","volume":"21","author":"GG Nair","year":"2019","unstructured":"Nair, G. G. et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells. Nat. Cell Biol. 21, 263\u2013274 (2019).","journal-title":"Nat. Cell Biol."},{"key":"64346_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","volume":"12","author":"L Velazco-Cruz","year":"2019","unstructured":"Velazco-Cruz, L. et al. Acquisition of dynamic function in human stem cell-derived beta cells. Stem Cell Rep. 12, 351\u2013365 (2019).","journal-title":"Stem Cell Rep."},{"key":"64346_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca, F. W. et al. Generation of functional human pancreatic \u03b2 cells in vitro. Cell 159, 428\u2013439 (2014).","journal-title":"Cell"},{"key":"64346_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.99","volume":"51","author":"JC Davis","year":"2019","unstructured":"Davis, J. C. et al. Live cell monitoring and enrichment of stem cell-derived \u03b2 cells using intracellular zinc content as a population marker. Curr. Protoc. Stem Cell Biol. 51, e99 (2019).","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"64346_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","volume":"40","author":"D Balboa","year":"2022","unstructured":"Balboa, D. et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol 40, 1042\u20131055 (2022).","journal-title":"Nat Biotechnol"},{"key":"64346_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.967765","author":"F Fantuzzi","year":"2022","unstructured":"Fantuzzi, F. et al. In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2022.967765 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"64346_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.71591","volume":"11","author":"RA Tomaz","year":"2022","unstructured":"Tomaz, R. A. et al. Generation of functional hepatocytes by forward programming with nuclear receptors. Elife 11, 1\u201325 (2022).","journal-title":"Elife"},{"key":"64346_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.stemcr.2019.11.005","volume":"14","author":"L Lange","year":"2020","unstructured":"Lange, L. et al. Inducible forward programming of human pluripotent stem cells to hemato-endothelial progenitor cells with hematopoietic progenitor potential. Stem Cell Rep. 14, 122\u2013137 (2020).","journal-title":"Stem Cell Rep."},{"key":"64346_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2012","unstructured":"Pang, Z. P. et al. Induction of human neuronal cells by defined transcription factors. NatureNature 476, 220\u2013223 (2012).","journal-title":"NatureNature"},{"key":"64346_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.stemcr.2014.05.020","volume":"3","author":"S Chanda","year":"2014","unstructured":"Chanda, S. et al. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep. 3, 282\u2013296 (2014).","journal-title":"Stem Cell Rep."},{"key":"64346_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.stemcr.2017.02.016","volume":"8","author":"M Pawlowski","year":"2017","unstructured":"Pawlowski, M. et al. Inducible and deterministic forward programming of human pluripotent stem cells into neurons, skeletal myocytes, and oligodendrocytes. Stem Cell Rep. 8, 803\u2013812 (2017).","journal-title":"Stem Cell Rep."},{"key":"64346_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/bloodadvances.2020003236","volume":"5","author":"AL Evans","year":"2021","unstructured":"Evans, A. L. et al. Transfer to the clinic: Refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors. Blood Adv. 5, 1977\u20131990 (2021).","journal-title":"Blood Adv."},{"key":"64346_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2123476119","volume":"119","author":"AM Speicher","year":"2022","unstructured":"Speicher, A. M. et al. Deterministic programming of human pluripotent stem cells into microglia facilitates studying their role in health and disease. Proc. Natl. Acad. Sci. U. S. A. 119, 1\u201311 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"64346_CR25","first-page":"1","volume":"6","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. Sci. Adv. 6, 1\u201315 (2020).","journal-title":"Sci. Adv."},{"key":"64346_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0963689720978739","volume":"30","author":"J Li","year":"2021","unstructured":"Li, J. et al. Upregulation of ETV2 expression promotes endothelial differentiation of human dental pulp stem cells. Cell Transplant. 30, 1\u201311 (2021).","journal-title":"Cell Transplant."},{"key":"64346_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.devcel.2007.06.001","volume":"13","author":"Q Zhou","year":"2007","unstructured":"Zhou, Q. et al. A multipotent progenitor domain guides pancreatic organogenesis. Dev. Cell 13, 103\u2013114 (2007).","journal-title":"Dev. Cell"},{"key":"64346_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13287-017-0694-z","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y., Liu, Q., Zhou, Z. & Ikeda, Y. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration. Stem Cell Res. Ther. 8, 240 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"64346_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nature07314","volume":"455","author":"Q Zhou","year":"2008","unstructured":"Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627\u2013632 (2008).","journal-title":"Nature"},{"key":"64346_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BJ20111678","volume":"442","author":"E Akinci","year":"2012","unstructured":"Akinci, E., Banga, A., Greder, L. V., Dutton, J. R. & Slack, J. M. Reprogramming of pancreatic exocrine cells towards a beta (beta) cell character using Pdx1, Ngn3 and MafA. Biochem. J. 442, 539\u2013550 (2012).","journal-title":"Biochem. J."},{"key":"64346_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.33","volume":"5","author":"T Koblas","year":"2016","unstructured":"Koblas, T., Leontovyc, I., Loukotova, S., Kosinova, L. & Saudek, F. Reprogramming of pancreatic exocrine cells AR42J into insulin-producing cells using mRNAs for Pdx1, Ngn3, and MafA transcription factors. Mol. Ther. - Nucleic Acids 5, e320 (2016).","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"64346_CR32","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1073\/pnas.1201701109","volume":"109","author":"A Banga","year":"2012","unstructured":"Banga, A., Akinci, E., Greder, L. V., Dutton, J. R. & Slack, J. M. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc. Natl. Acad. Sci. U. S. A. 109, 15336\u201315341 (2012).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"64346_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/gt.2013.50","volume":"21","author":"A Banga","year":"2014","unstructured":"Banga, A., Greder, L. V., Dutton, J. R. & Slack, J. M. W. Stable insulin secreting ducts formed by reprogramming of cells in the liver using a three gene cocktail and a PPAR agonist. Gene Ther. 21, 19\u201327 (2014).","journal-title":"Gene Ther."},{"key":"64346_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082424","volume":"8","author":"E Akinci","year":"2013","unstructured":"Akinci, E. et al. Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA. PLoS One 8, e82424 (2013).","journal-title":"PLoS One"},{"key":"64346_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2337\/db16-0887","volume":"66","author":"TA Matsuoka","year":"2017","unstructured":"Matsuoka, T. A. et al. Mafa enables Pdx1 to effectively convert pancreatic islet progenitors and committed islet \u03b1-cells into \u03b2-cells in vivo. Diabetes 66, 1293\u20131300 (2017).","journal-title":"Diabetes"},{"key":"64346_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omtm.2023.02.003","volume":"28","author":"P Guo","year":"2023","unstructured":"Guo, P. et al. Specific reprogramming of alpha cells to insulin-producing cells by short glucagon promoter-driven Pdx1 and MafA. Mol. Ther. - Methods Clin. Dev. 28, 355\u2013365 (2023).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"64346_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3727\/096368912X653057","volume":"22","author":"H Xu","year":"2013","unstructured":"Xu, H. et al. The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells. Cell Transplant. 22, 147\u2013158 (2013).","journal-title":"Cell Transplant."},{"key":"64346_CR38","doi-asserted-by":"publisher","first-page":"11247","DOI":"10.1038\/ncomms11247","volume":"7","author":"P Saxena","year":"2016","unstructured":"Saxena, P. et al. A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells. Nat. Commun. 7, 11247 (2016).","journal-title":"Nat. Commun."},{"key":"64346_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101961","volume":"48","author":"R Stock","year":"2020","unstructured":"Stock, R. et al. Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control. Stem Cell Res. 48, 101961 (2020).","journal-title":"Stem Cell Res."},{"key":"64346_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.matbio.2022.12.005","volume":"115","author":"M Urbanczyk","year":"2023","unstructured":"Urbanczyk, M. et al. Decorin improves human pancreatic \u03b2-cell function and regulates ECM expression in vitro. Matrix Biol. 115, 160\u2013183 (2023).","journal-title":"Matrix Biol."},{"key":"64346_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/stmcls\/sxac020","volume":"40","author":"MS Poetsch","year":"2022","unstructured":"Poetsch, M. S., Strano, A. & Guan, K. Human induced pluripotent stem cells: from cell origin, genomic stability, and epigenetic memory to translational medicine. Stem Cells 40, 546\u2013555 (2022).","journal-title":"Stem Cells"},{"key":"64346_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285\u2013290 (2010).","journal-title":"Nature"},{"key":"64346_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ncb2239","volume":"13","author":"Y Ohi","year":"2011","unstructured":"Ohi, Y. et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13, 541\u2013549 (2011).","journal-title":"Nat. Cell Biol."},{"key":"64346_CR44","first-page":"1","volume":"1","author":"S Hu","year":"2016","unstructured":"Hu, S. et al. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. J. Clin. Invest. 1, 1\u201312 (2016).","journal-title":"J. Clin. Invest."},{"key":"64346_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21165705","volume":"21","author":"P Chlebanowska","year":"2020","unstructured":"Chlebanowska, P. et al. Origin of the induced pluripotent stem cells affects their differentiation into dopaminergic neurons. Int. J. Mol. Sci. 21, 1\u201323 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"64346_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107623","volume":"31","author":"JC Davis","year":"2020","unstructured":"Davis, J. C. et al. Glucose response by stem cell-derived beta cells in vitro is inhibited by a bottleneck in glycolysis. Cell Rep. 31, 107623 (2020).","journal-title":"Cell Rep."},{"key":"64346_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1236472","volume":"14","author":"IT Jasra","year":"2023","unstructured":"Jasra, I. T., Cuesta-gomez, N., Verhoeff, K. & Shapiro, A. M. J. Mitochondrial regulation in human pluripotent stem cells during reprogramming and b cell differentiation. Front. Endocrinol. (Lausanne) 14, 1\u201317 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"64346_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","volume":"6","author":"A Kytt\u00e4l\u00e4","year":"2016","unstructured":"Kytt\u00e4l\u00e4, A. et al. Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep. 6, 200\u2013212 (2016).","journal-title":"Stem Cell Rep."},{"key":"64346_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370 (2017).","journal-title":"Nature"},{"key":"64346_CR50","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41556-023-01130-y","volume":"25","author":"X Huang","year":"2023","unstructured":"Huang, X. et al. Stomach-derived human insulin-secreting organoids restore glucose homeostasis. Nat. Cell Biol. 25, 778\u2013786 (2023).","journal-title":"Nat. Cell Biol."},{"key":"64346_CR51","first-page":"139","volume":"176","author":"C Ariyachet","year":"2017","unstructured":"Ariyachet, C. et al. Reprogrammed stomach tissue as a renewable source of functional \u03b2 cells for blood glucose regulation. Cell Stem Cell 176, 139\u2013148 (2017).","journal-title":"Cell Stem Cell"},{"key":"64346_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04627-2","volume":"6","author":"M Fontcuberta-PiSunyer","year":"2023","unstructured":"Fontcuberta-PiSunyer, M. et al. Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors. Commun. Biol. 6, 1\u201315 (2023).","journal-title":"Commun. Biol."},{"key":"64346_CR53","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.omtm.2020.04.016","volume":"17","author":"I Santeramo","year":"2020","unstructured":"Santeramo, I. et al. Vector copy distribution at a single-cell level enhances analytical characterization of gene-modified cell therapies. Mol. Ther. - Methods Clin. Dev. 17, 944\u2013956 (2020).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"64346_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cancers12020375","volume":"12","author":"K Zimmermann","year":"2020","unstructured":"Zimmermann, K. et al. Design and characterization of an \u201call-in-one\u201d lentiviral vector system combining constitutive anti-G. Cancers Basel. 12, 375 (2020).","journal-title":"Cancers Basel."},{"key":"64346_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","volume":"5","author":"PI Ortinski","year":"2017","unstructured":"Ortinski, P. I., O\u2019Donovan, B., Dong, X. & Kantor, B. Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-mediated gene editing. Mol. Ther. - Methods Clin. Dev. 5, 153\u2013164 (2017).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"64346_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1006554","volume":"13","author":"K Ishikawa","year":"2017","unstructured":"Ishikawa, K., Makanae, K., Iwasaki, S., Ingolia, N. T. & Moriya, H. Post-translational dosage compensation buffers genetic perturbations to stoichiometry of protein complexes. PLoS Genet. 13, 1\u201322 (2017).","journal-title":"PLoS Genet."},{"key":"64346_CR57","first-page":"e100637","volume":"9","author":"RW Daniels","year":"2014","unstructured":"Daniels, R. W., Rossano, A. J., Macleod, G. T. & Ganetzky, B. Expression of Multiple Transgenes from a Single Construct Using Viral 2A Peptides in Drosophila. Expert Opin. Biol. Therapy 9, e100637 (2014).","journal-title":"Expert Opin. Biol. Therapy"},{"key":"64346_CR58","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1517\/14712598.5.5.627","volume":"5","author":"AL Szymczak","year":"2005","unstructured":"Szymczak, A. L. & Vignali, D. A. A. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin. Biol. Ther. 5, 627\u2013638 (2005).","journal-title":"Expert Opin. Biol. Ther."},{"key":"64346_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5661\/bger-26-223","volume":"26","author":"GA Luke","year":"2009","unstructured":"Luke, G. A., Escuin, H., Felipe, P. D. & Ryan, M. D. 2A to the fore \u2013 research, technology and applications 2A to the fore \u2013 research, technology and applications. Biotechnol. Genet. Eng. Rev. 26, 223\u2013260 (2009).","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"64346_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02460-2","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Chen, O., Wall, J. B. J., Zheng, M. & Zhou, Y. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-02460-2 (2017).","journal-title":"Sci. Rep."},{"key":"64346_CR61","first-page":"509","volume":"11","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Retinal cell type DNA methylation and histone modifications predict reprogramming efficiency and retinogenesis in 3D organoid cultures. Cell Rep. 11, 509\u2013533 (2018).","journal-title":"Cell Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64346-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:07:02Z","timestamp":1718244422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64346-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["64346"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-64346-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3658114\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13608"}}